248 related articles for article (PubMed ID: 20978134)
21. Vitamin K epoxide reductase: homology, active site and catalytic mechanism.
Goodstadt L; Ponting CP
Trends Biochem Sci; 2004 Jun; 29(6):289-92. PubMed ID: 15276181
[TBL] [Abstract][Full Text] [Related]
22. Identification of the Thioredoxin Partner of Vitamin K Epoxide Reductase in Mycobacterial Disulfide Bond Formation.
Ke N; Landeta C; Wang X; Boyd D; Eser M; Beckwith J
J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29784887
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.
Tie JK; Jin DY; Tie K; Stafford DW
J Thromb Haemost; 2013 Aug; 11(8):1556-64. PubMed ID: 23710884
[TBL] [Abstract][Full Text] [Related]
24. The catalytic mechanism of vitamin K epoxide reduction in a cellular environment.
Shen G; Cui W; Cao Q; Gao M; Liu H; Su G; Gross ML; Li W
J Biol Chem; 2021; 296():100145. PubMed ID: 33273012
[TBL] [Abstract][Full Text] [Related]
25. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2.
Chu PH; Huang TY; Williams J; Stafford DW
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19308-13. PubMed ID: 17164330
[TBL] [Abstract][Full Text] [Related]
26. Membrane topology mapping of vitamin K epoxide reductase by in vitro translation/cotranslocation.
Tie JK; Nicchitta C; von Heijne G; Stafford DW
J Biol Chem; 2005 Apr; 280(16):16410-6. PubMed ID: 15716279
[TBL] [Abstract][Full Text] [Related]
27. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
28. A quantum chemical study of the mechanism of action of Vitamin K epoxide reductase (VKOR) II. Transition states.
Davis CH; Deerfield D; Wymore T; Stafford DW; Pedersen LG
J Mol Graph Model; 2007 Sep; 26(2):401-8. PubMed ID: 17182266
[TBL] [Abstract][Full Text] [Related]
29. Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
Czogalla KJ; Biswas A; Höning K; Hornung V; Liphardt K; Watzka M; Oldenburg J
Nat Struct Mol Biol; 2017 Jan; 24(1):77-85. PubMed ID: 27941861
[TBL] [Abstract][Full Text] [Related]
30. Conserved loop cysteines of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are involved in its active site regeneration.
Tie JK; Jin DY; Stafford DW
J Biol Chem; 2014 Mar; 289(13):9396-407. PubMed ID: 24532791
[TBL] [Abstract][Full Text] [Related]
31. Structural and cellular basis of vitamin K antagonism.
Liu S; Shen G; Li W
J Thromb Haemost; 2022 Sep; 20(9):1971-1983. PubMed ID: 35748323
[TBL] [Abstract][Full Text] [Related]
32. A new model for vitamin K-dependent carboxylation: the catalytic base that deprotonates vitamin K hydroquinone is not Cys but an activated amine.
Rishavy MA; Pudota BN; Hallgren KW; Qian W; Yakubenko AV; Song JH; Runge KW; Berkner KL
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13732-7. PubMed ID: 15365175
[TBL] [Abstract][Full Text] [Related]
33. Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.
Rishavy MA; Hallgren KW; Wilson L; Singh S; Runge KW; Berkner KL
Blood; 2018 Jun; 131(25):2826-2835. PubMed ID: 29592891
[TBL] [Abstract][Full Text] [Related]
34. Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.
Wu S; Chen X; Jin DY; Stafford DW; Pedersen LG; Tie JK
Blood; 2018 Aug; 132(6):647-657. PubMed ID: 29743176
[TBL] [Abstract][Full Text] [Related]
35. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle.
Oldenburg J; Bevans CG; Müller CR; Watzka M
Antioxid Redox Signal; 2006; 8(3-4):347-53. PubMed ID: 16677080
[TBL] [Abstract][Full Text] [Related]
36. Structural and functional insights into enzymes of the vitamin K cycle.
Tie JK; Stafford DW
J Thromb Haemost; 2016 Feb; 14(2):236-47. PubMed ID: 26663892
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1.
Van Horn WD
Crit Rev Biochem Mol Biol; 2013; 48(4):357-72. PubMed ID: 23631591
[TBL] [Abstract][Full Text] [Related]
38. Distinct enzymatic strategies for
Li W
Crit Rev Biochem Mol Biol; 2023 Feb; 58(1):36-49. PubMed ID: 37098102
[TBL] [Abstract][Full Text] [Related]
39. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
[TBL] [Abstract][Full Text] [Related]
40. Phylogeny of the Vitamin K 2,3-Epoxide Reductase (VKOR) Family and Evolutionary Relationship to the Disulfide Bond Formation Protein B (DsbB) Family.
Bevans CG; Krettler C; Reinhart C; Watzka M; Oldenburg J
Nutrients; 2015 Jul; 7(8):6224-49. PubMed ID: 26230708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
